12:00 AM
Jun 29, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bepreve regulatory update

FDA's Dermatologic and Ophthalmic Drugs Advisory Committee voted 7-0 on Friday to recommend approval of Ista's Bepreve bepotastine to treat ocular itching associated with allergic conjunctivitis. The PDUFA...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >